IMIC Research gets accepted in MAGI Blue Ribbon Sites


IMIC Research

Blue Ribbon Site

IMIC Research as a research clinic in Miami and following quality review is accepted as a Blue Ribbon site in MAGI, one of the leading research organizations.

PALMETTO BAY, FLORIDA, UNITED STATES, September 30, 2018 / — IMIC Research is a dedicated clinical research site in Palmetto Bay, FL. The site participates in research studies sponsored by pharmaceutical companies in different fields. These studies help advance the medicine and the development of new medications.

Model Agreements & Guidelines International (MAGI) is streamlining clinical research by standardizing best practices for clinical operations, business and regulatory compliance. MAGI is one of the research organizations that host yearly research conferences to educate the research community, dedicated to advancing the practice of clinical research and provide free, highly informative, non-promotional webinars.

The MAGI Blue Ribbon Sites program promotes a culture of excellence in the clinical site community by:
-Publishing a directory of excellent sites so they can grow and do more excellent research
-Facilitating collaborations and shared best practices among the members so they can become even more excellent
-Partnering with leading product and service providers to help members find superior solutions at discounted prices
-Encouraging other sites to become excellent so they can join the program
MAGI Blue Ribbon Sites meet the following criteria:
-Have been conducting clinical research for at least five years
-Conduct enough clinical research to ensure stability (e.g., have at least two full-time study coordinators)
-Start studies quickly
-Have consistently met enrollment commitments in the past year for at least one investigator in at least one therapeutic indication
-Maintain a substantial database of potential study subjects
-Accept ethical review by accredited central IRBs, or a local IRB that meets the same standards for timeliness
-Are a member of at least one selective site network or CRO/sponsor preferred site program (preferred)
-Have a sterling reputation among study sponsors, CROs and other MAGI Blue Ribbon Sites

Having met all the above IMIC Research is accepted in The Blue Ribbon Sites Program as of 09/28/2018.

IMIC Inc is a private company in Palmetto Bay, FL. President is Aimee Cabo, CEO is Boris Nikolov. IMIC Research has been incorporated since 2006 in Florida. IMIC Research is curently working on 32 research studies as one of the dedicated sites of the global programs of many pharmaceutical companies. Current research studies are enrolling new patients in Diabetes, Asthma, Ulcerative Colitis, Crohn's disease, Liver Cirrhosis, ADHD, Tourette's syndrome, Alzheimer's disease, Bipolar disorder, NASH, among others. IMIC Research has succesfully enrolled more than 1500 patienst in more than 100 research studies in the past 10 years.

Boris Nikolov
IMIC Research
email us here
Visit us on social media:


Source: EIN Presswire